Revance Therapeutics, Inc. (NASDAQ:RVNC) Q4 2020 Earnings Conference Call February 22, 2021 4:30 PM ET Company Participants Jessica Serra - Head of Investor Relations and ESG Mark Foley - President and Chief Executive Officer Toby Schilke - Chief Financial Officer Roman Rubio - Senior Vice President Clinical Development Dustin Sjuts - Chief Commercial Officer, Therapeutics & Aesthetics Abhay Joshi - Chief Operating Officer and President of R&D and Product Operation Conference Call Participants Ken Cacciator ...